Our ongoing study indicates that naïve CD271+ BM-MSCs exhibit anti-tumor activity (Talukdar et al., 2016) on migratory cancer side population (SPm) cells, a type of cancer stem cells having high metastatic potential (Das et al., 2008b). The gene discussed is NGFR; the disease is neoplasm.